Statistics for Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls
Total visits
| views | |
|---|---|
| Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls | 151 |
Total visits per month
| views | |
|---|---|
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
File Visits
| views | |
|---|---|
| nihms-1044187.pdf | 144 |
| java.util.UUID:78c49170-83e7-4ec3-a7d5-489df0b08e49 | 43 |
| java.util.UUID:b41e1515-cf0e-420a-bbe6-c09ef287f0e8 | 9 |
| java.util.UUID:4f79e39e-434f-4946-8696-9e57678c2136 | 8 |
Top country views
| views | |
|---|---|
| United States | 116 |
| China | 7 |
| Germany | 6 |
| Ukraine | 5 |
| Canada | 2 |
| United Kingdom | 1 |
| Malaysia | 1 |
| Russia | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 49 |
| Fairfield | 20 |
| Cambridge | 6 |
| Houston | 5 |
| Jacksonville | 5 |
| Kiev | 5 |
| Kiez | 4 |
| Shenzhen | 4 |
| Beijing | 3 |
| Toronto | 2 |
| Gunzenhausen | 1 |
| Kansas City | 1 |
| Moscow | 1 |
| Munich | 1 |
| San Francisco | 1 |
| Seattle | 1 |
| Seremban | 1 |
| Washington | 1 |